FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890862274> ?p ?o ?g. }

• W2890862274 endingPage "88" @default.
• W2890862274 startingPage "84" @default.
• W2890862274 abstract "Non-fermenting Gram-negative bacteria (NFGNB) are increasingly cultured in respiratory samples from cystic fibrosis (CF) patients. This study determined the antimicrobial susceptibility of clinical CF respiratory isolates from distinct geographical regions. A total of 286 isolates (106 Stenotrophomonas maltophilia, 100 Burkholderia spp., 59 Achromobacter spp., 12 Pandoraea spp., 9 Ralstonia spp.) from the Netherlands, Northern Ireland, Spain, USA and Australia were tested. MIC50/90 values and susceptibility categorisation were determined. Trimethoprim/sulfamethoxazole (SXT) was the most active compound for all micro-organisms (MIC50, 0.12–4 mg/L; MIC90, 1–16 mg/L). For S. maltophilia, 47% and 62% of isolates were susceptible to SXT according to CLSI and EUCAST breakpoints, respectively. Ceftazidime presented lower susceptibility (35%; MIC50, 32 mg/L; MIC90, 256 mg/L). MIC90 values for tobramycin and colistin were >128 mg/L and >16 mg/L, respectively. Regarding Burkholderia, 72%, 56% and 44% were susceptible to SXT, ceftazidime and meropenem, respectively. For both ceftazidime and meropenem, MIC50 and MIC90 values were within the intermediate or resistant category. The most active antibiotics for Achromobacter spp. were SXT (MIC50, 0.5 mg/L; MIC90, 8 mg/L) and imipenem (MIC50, 2 mg/L; MIC90, 8 mg/L). SXT, imipenem and ciprofloxacin were active against 12 Pandoraea spp. (MIC50, 0.12–4 mg/L; MIC90, 1–8 mg/L). Ciprofloxacin (MIC50, 4 mg/L) and SXT (MIC50, 1 mg/L) were the only active antibiotics for Ralstonia spp. There were no statistically significant differences in susceptibility rates between countries. NFGNB other than Pseudomonas aeruginosa are potential pathogens in CF. SXT was demonstrated to be the most active compound against these isolates." @default.
• W2890862274 created "2018-09-27" @default.
• W2890862274 creator A5002135002 @default.
• W2890862274 creator A5016535882 @default.
• W2890862274 creator A5018151796 @default.
• W2890862274 creator A5029665155 @default.
• W2890862274 creator A5036220332 @default.
• W2890862274 creator A5052945060 @default.
• W2890862274 creator A5054113428 @default.
• W2890862274 creator A5068631439 @default.
• W2890862274 creator A5075234742 @default.
• W2890862274 creator A5091128796 @default.
• W2890862274 date "2019-01-01" @default.
• W2890862274 modified "2023-10-18" @default.
• W2890862274 title "Antimicrobial susceptibility of non-fermenting Gram-negative pathogens isolated from cystic fibrosis patients" @default.
• W2890862274 cites W1890376985 @default.
• W2890862274 cites W1921056904 @default.
• W2890862274 cites W1968699566 @default.
• W2890862274 cites W1969511733 @default.
• W2890862274 cites W2059184280 @default.
• W2890862274 cites W2138881115 @default.
• W2890862274 cites W2139186193 @default.
• W2890862274 cites W2140715227 @default.
• W2890862274 cites W2141094462 @default.
• W2890862274 cites W2141585349 @default.
• W2890862274 cites W2144124312 @default.
• W2890862274 cites W2147695950 @default.
• W2890862274 cites W2332152786 @default.
• W2890862274 cites W2587349814 @default.
• W2890862274 cites W2608308533 @default.
• W2890862274 cites W2620134264 @default.
• W2890862274 doi "https://doi.org/10.1016/j.ijantimicag.2018.09.001" @default.
• W2890862274 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30240837" @default.
• W2890862274 hasPublicationYear "2019" @default.
• W2890862274 type Work @default.
• W2890862274 sameAs 2890862274 @default.
• W2890862274 citedByCount "25" @default.
• W2890862274 countsByYear W28908622742019 @default.
• W2890862274 countsByYear W28908622742020 @default.
• W2890862274 countsByYear W28908622742021 @default.
• W2890862274 countsByYear W28908622742022 @default.
• W2890862274 countsByYear W28908622742023 @default.
• W2890862274 crossrefType "journal-article" @default.
• W2890862274 hasAuthorship W2890862274A5002135002 @default.
• W2890862274 hasAuthorship W2890862274A5016535882 @default.
• W2890862274 hasAuthorship W2890862274A5018151796 @default.
• W2890862274 hasAuthorship W2890862274A5029665155 @default.
• W2890862274 hasAuthorship W2890862274A5036220332 @default.
• W2890862274 hasAuthorship W2890862274A5052945060 @default.
• W2890862274 hasAuthorship W2890862274A5054113428 @default.
• W2890862274 hasAuthorship W2890862274A5068631439 @default.
• W2890862274 hasAuthorship W2890862274A5075234742 @default.
• W2890862274 hasAuthorship W2890862274A5091128796 @default.
• W2890862274 hasBestOaLocation W28908622742 @default.
• W2890862274 hasConcept C2776352461 @default.
• W2890862274 hasConcept C2776968632 @default.
• W2890862274 hasConcept C2777287306 @default.
• W2890862274 hasConcept C2777637488 @default.
• W2890862274 hasConcept C2778512257 @default.
• W2890862274 hasConcept C2778523567 @default.
• W2890862274 hasConcept C2779375183 @default.
• W2890862274 hasConcept C2779631663 @default.
• W2890862274 hasConcept C2779657461 @default.
• W2890862274 hasConcept C2780416669 @default.
• W2890862274 hasConcept C2781463711 @default.
• W2890862274 hasConcept C501593827 @default.
• W2890862274 hasConcept C523546767 @default.
• W2890862274 hasConcept C54355233 @default.
• W2890862274 hasConcept C86803240 @default.
• W2890862274 hasConcept C89423630 @default.
• W2890862274 hasConcept C94665300 @default.
• W2890862274 hasConceptScore W2890862274C2776352461 @default.
• W2890862274 hasConceptScore W2890862274C2776968632 @default.
• W2890862274 hasConceptScore W2890862274C2777287306 @default.
• W2890862274 hasConceptScore W2890862274C2777637488 @default.
• W2890862274 hasConceptScore W2890862274C2778512257 @default.
• W2890862274 hasConceptScore W2890862274C2778523567 @default.
• W2890862274 hasConceptScore W2890862274C2779375183 @default.
• W2890862274 hasConceptScore W2890862274C2779631663 @default.
• W2890862274 hasConceptScore W2890862274C2779657461 @default.
• W2890862274 hasConceptScore W2890862274C2780416669 @default.
• W2890862274 hasConceptScore W2890862274C2781463711 @default.
• W2890862274 hasConceptScore W2890862274C501593827 @default.
• W2890862274 hasConceptScore W2890862274C523546767 @default.
• W2890862274 hasConceptScore W2890862274C54355233 @default.
• W2890862274 hasConceptScore W2890862274C86803240 @default.
• W2890862274 hasConceptScore W2890862274C89423630 @default.
• W2890862274 hasConceptScore W2890862274C94665300 @default.
• W2890862274 hasFunder F4320326631 @default.
• W2890862274 hasIssue "1" @default.
• W2890862274 hasLocation W28908622741 @default.
• W2890862274 hasLocation W28908622742 @default.
• W2890862274 hasLocation W28908622743 @default.
• W2890862274 hasOpenAccess W2890862274 @default.
• W2890862274 hasPrimaryLocation W28908622741 @default.
• W2890862274 hasRelatedWork W2080932213 @default.
• W2890862274 hasRelatedWork W2104071021 @default.
• W2890862274 hasRelatedWork W2152910084 @default.

• next